Search results
What’s going on with the ImmunityBio (IBRX) stock price?
Invezz· 5 days agoImmunityBio shares have been in a strong bull run this year, helped by the recent FDA approval of...
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 2 days agoModerna detailed plans for its individual neoantigen cancer vaccine in a first-quarter earnings...
Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 9 hours agoModerna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript May 2, 2024 Moderna, Inc. beats...
Incyte's (INCY) Q1 Earnings & Revenues Fall Shy of Estimates
Zacks via Yahoo Finance· 4 days agoJakavi royalties beat the Zacks Consensus Estimate of $86 million. Incyte also receives royalties...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 2 days agoModerna/Merck also started two separate mid-stage studies in renal cell carcinoma and...
A decades-old FDA rule is keeping Americans from having better sunscreen
NBC Universal via AOL· 12 hours agoThe FDA's ability to approve the chemical filters in sunscreens that are sold in other countries is...
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies - Cell...
Nature· 3 days agoForkhead box protein M1 (FOXM1) is often overexpressed in human cancers and strongly associated with therapy resistance and less good patient survival. The chemotherapy options for patients ...
Resource-Appropriate Cancer Care, Including Coexisting Health Issues of HIV and Cancer, to be...
Newswise· 4 days agoInternational collaboration to improve cancer outcomes in Sub-Saharan Africa is working to update...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 2 days agoA Phase 3 study is already underway with the initial results expected later this decade. But at...
...Clinical Trials Investigating REM-422 for Treatment of Adenoid Cystic Carcinoma (ACC) and Acute...
CBS 47 Fresno· 3 days agoRemix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address underlying drivers of disease ...